Neurology® Podcast

Dr. Halley Alexander talks with Dr. Samuel W. Terman about patients' perceived seizure risk, seizure risk tolerance, and risk counseling techniques.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Dr. Katie Krulisky talks with Dr. Leah Blank about the impact of outpatient follow-up on readmission rates for older adults with epilepsy or seizures. Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

Dr. Halley Alexander talks with Dr. Coral M. Stredny about the management of pediatric convulsive status epilepticus, focusing on the importance of seizure action plans and adherence to treatment protocols.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Dr. Nadia Khalil talks with Dr. Jean Bouchart about the diagnostic approach to intracerebral hemorrhage, the causes of cerebral small vessel disease, and the interpretation of biomolecular tests.  Read the related article in Neurology® Resident & Fellow Section.  Disclosures can be found at Neurology.org. 

Join experts Cheryl Bushnell, a leading neurologist and chair of AHA-ASA guidelines, Phillip Ferdinand, a stroke physician at Royal Stoke University, Aaron Shoskes from the University of Utah, and Seemant Chaturvedi, director of stroke neurology at the University of Maryland. They dive into new primary stroke prevention guidelines, the alarming relationship between smoking and strokes in young adults, and the evolving landscape of vascular risk factors among younger populations. Discover critical insights from the latest international conference on stroke!

Dr. Sumanth Reddy and Dr. Jeffrey Gelfand, both neurologists at UCSF, dive into the intricate world of small vessel primary CNS vasculitis. They discuss the complex clinical features and the vital role of biopsy confirmation for accurate diagnosis. The doctors advocate for early use of cyclophosphamide over glucocorticoids to expedite remission. They also explore the challenges of defining remission and the importance of spinal fluid testing in monitoring disease activity, emphasizing collaborative treatment approaches for better patient outcomes.

Join Dr. Greg Cooper as he chats with Dr. David A. Wolk, a distinguished neurologist from the University of Pennsylvania, specializing in LATE. They delve into the nuances of limbic predominant age-related TDP-43 encephalopathy, highlighting its critical links to cognitive decline and Alzheimer's disease. The discussion covers the evolving recognition of LATE, challenges in accurate diagnosis, and the importance of advanced biomarkers like FDG PET imaging. Wolk's insights shed light on LATE's distinct clinical features and the urgency for better diagnostic tools.

Dr. Stacey Clardy talks with Dr. Elia Sechi about the importance of understanding lab test results, the performance characteristics of assays, and the real-world implications of false positives in myasthenia gravis testing. Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Dr. Roy E. Strowd talks with Dr. Susannah Cornes about a teaching incentive initiative designed to support and reward faculty in academic neurology.  Read the related article in Neurology® Education.  Disclosures can be found at Neurology.org. 

Dr. Per Borghammer, a physician researcher from Aarhus University, dives into groundbreaking insights on Lewy body disease. He discusses the crucial distinction between brain-first and body-first subtypes, highlighting newly identified parasympathetic and sympathetic variations. Borghammer explores how these classifications impact symptom development, proving vital for precision medicine. He also addresses the challenges of diagnosing preclinical stages of Parkinson's, emphasizing the importance of analyzing non-brain tissues to improve early detection.